Clinical Trials Directory

Trials / Completed

CompletedNCT00531713

Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism

Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism,a Double Blind Randomized Cross-Over Study.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
59 (actual)
Sponsor
Copenhagen University Hospital at Herlev · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To compare the effect of T4-T3 combination therapy versus T4 monotherapy in patients with autoimmune hypothyroidism, on stable T4-substitution therapy

Detailed description

double blind randomized cross-over study.

Conditions

Interventions

TypeNameDescription
DRUGTriiodothyronine50 microgram of the usual T4 is withdrawn and the patients is given 20 microgram of T3

Timeline

Start date
2003-04-01
Completion
2007-03-01
First posted
2007-09-19
Last updated
2007-09-19

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00531713. Inclusion in this directory is not an endorsement.